Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Replimune Group
REPL
$1.42B
| $6.08M | ﹤0.01% |
205,256
+23,962
| +13% | +$778K |
|
2277
New Fortress Energy
NFE
$93M
| $6.08M | ﹤0.01% |
219,143
-20,544
| -9% | -$620K |
|
|
LBAI
2278
DELISTED
Lakeland Bancorp Inc
LBAI
| $6.08M | ﹤0.01% |
344,558
-1,301
| -0.4% | -$21.6K |
|
2279
Stoneridge
SRI
$201M
| $6.07M | ﹤0.01% |
297,582
+14,781
| +5% | +$366K |
|
2280
Citi Trends
CTRN
$621M
| $6.05M | ﹤0.01% |
82,881
-17,542
| -17% | -$1.4M |
|
2281
Monarch Casino & Resort
MCRI
$2.2B
| $6.04M | ﹤0.01% |
90,164
+666
| +0.7% | +$43.1K |
|
2282
Liberty Media Series A
FWONA
$23.7B
| $6.04M | ﹤0.01% |
133,970
-3,543
| -3% | -$149K |
|
2283
Vaxcyte
PCVX
$8.76B
| $6.03M | ﹤0.01% |
237,748
+65,145
| +38% | +$1.58M |
|
2284
United Fire Group
UFCS
$1.38B
| $6.02M | ﹤0.01% |
260,698
+14,332
| +6% | +$358K |
|
2285
Artivion
AORT
$1.39B
| $6.01M | ﹤0.01% |
269,563
+2,959
| +1% | +$76.2K |
|
|
MNRL
2286
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $5.98M | ﹤0.01% |
312,081
+44,862
| +17% | +$862K |
|
|
MCHB
2287
Mechanics Bancorp
MCHB
$3.79B
| $5.97M | ﹤0.01% |
145,206
-2,252
| -2% | -$88K |
|
|
MMP
2288
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $5.97M | ﹤0.01% |
131,071
-5,668
| -4% | -$269K |
|
2289
Inogen
INGN
$154M
| $5.96M | ﹤0.01% |
138,426
+8,146
| +6% | +$501K |
|
2290
Corsair Gaming
CRSR
$1.45B
| $5.96M | ﹤0.01% |
229,895
+26,206
| +13% | +$751K |
|
2291
Harmonic Inc
HLIT
$1.42B
| $5.95M | ﹤0.01% |
679,538
+6,906
| +1% | +$61.8K |
|
|
PRMW
2292
DELISTED
Primo Water Corporation
PRMW
| $5.95M | ﹤0.01% |
378,236
+3,255
| +0.9% | +$54.8K |
|
|
CELL
2293
DELISTED
PhenomeX Inc. Common Stock
CELL
| $5.95M | ﹤0.01% |
303,974
+157,844
| +108% | +$6M |
|
2294
Rackspace Technology
RXT
$1.1B
| $5.94M | ﹤0.01% |
417,571
+133,368
| +47% | +$2.14M |
|
2295
MGP Ingredients
MGPI
$389M
| $5.94M | ﹤0.01% |
91,177
-1,819
| -2% | -$117K |
|
2296
Omeros
OMER
$1.26B
| $5.93M | ﹤0.01% |
429,988
+4,037
| +0.9% | +$60.4K |
|
|
EFC
2297
Ellington Financial
EFC
$1.76B
| $5.92M | ﹤0.01% |
323,884
+27,144
| +9% | +$498K |
|
|
TTCF
2298
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
| $5.9M | ﹤0.01% |
320,123
+36,591
| +13% | +$724K |
|
|
KRON
2299
DELISTED
Kronos Bio
KRON
| $5.88M | ﹤0.01% |
280,585
+134,534
| +92% | +$2.89M |
|
2300
Collegium Pharmaceutical
COLL
$913M
| $5.87M | ﹤0.01% |
297,226
+1,771
| +0.6% | +$38.3K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.